Corey Michael Watton insider trades

Open-market stock purchases and sales by Corey Michael Watton, Director at Zevra Therapeutics, Inc, from SEC Form 4 filings since May 3, 2023.

Track record: 100% of 5 scored buys are up 5% or more since purchase, averaging +94%.

Recent trades

DateStockTradeValue
Aug 10, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Aug 10, 2026ZVRA Zevra Therapeutics, IncSold$138K
Jun 4, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: 5 buys, 1 sale, last Aug 10, 2026

Get free alerts when Corey Michael Watton files a new trade →